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Abstract 
Introduction 
A between-subjects experiment examines the effects of different warning types and modified risk e-
cigarette ad claims on adolescent e-cigarette craving and future e-cigarette susceptibility for two 
different themes. One theme focuses on nicotine and addiction, and the other on the effects of 
potentially harmful constituents (eg, flavored chemicals and lung disease). 
Methods 
The effects of warning type (control, text-only, graphic health warning [GHW] and text) and modified 
risk e-cigarette ad claims (control, exposure reduction, risk reduction) are tested experimentally with 
two different arms (themes) for a sample of 1011 adolescents who had tried either e-cigarettes or 
cigarettes. 
Results 
For addiction, the text-only warning led to significantly less e-cigarette susceptibility than the no 
warning control condition. As expected, there were no differences between the GHW + text condition 
and text-only or control conditions for e-cigarette craving. An interaction between warning type and 
modified risk claims revealed significantly fewer e-cigarette cravings and less susceptibility for the text-
only warning and no claim (control) condition than for any other condition. For fatal lung disease, the 
GHW + text condition led to fewer e-cigarette cravings and less susceptibility than the text-only 
warning and no warning (control) conditions. 
Conclusions 
Warning type effects can be very different under different themes (eg, addiction, fatal lung disease). In 
general, our results point to the effectiveness of the text-only warning for addiction and GHW + text 
for fatal lung disease. Relative exposure and risk modification claims (eg, less nicotine; less addicting) 
tend to undercut addiction warnings. 
Implications 
More than one type of e-cigarette warning may be necessary as e-cigarette research evolves. Our 
results show different warning type effects (eg, text-only; GHW + text) on e-cigarette craving and 
future susceptibility for adolescent experimenters depending on the risk theme (eg, addiction; lung 
disease) and presence of ad claims (eg, exposure and risk reduction). As research emerges on risks 
associated with e-cigarette use, it is important to first know what at-risk populations (eg, adolescents) 
believe about such risks. Such research will aid our understanding of what types of warnings might be 
most effective, especially in the presence of ad claims. 
Topic 
 Nicotine, lung diseases, adolescent, addictive behavior, cigarettes, electronic cigarettes, craving 
Introduction 
As the single most preventable cause of death in the United States today, cigarette smoking causes 
about one of every five deaths in the United States, a total of almost 483000 deaths each year.1 This 
also is a global tragedy, contributing to some 7 million deaths worldwide.2 Smoking has been described 
accurately as a pediatric disease, as approximately 88% of current smokers begin smoking before age 
18.3–5 As nicotine is a highly addictive drug, smoking is very difficult to stop, with approximately 69% of 
current adult smokers trying and failing to quit.1 In the United States, the use of multiple tobacco 
products is growing, with 32% of adults using at least one tobacco product, even though only 18% are 
cigarette smokers.6 The trend toward dual- or poly-use is a concern for young experimenters, 
especially for new tobacco products, such as e-cigarettes (e-cigs), vaping tanks, and hookah. In fact, 
one-third of youth now perceive e-cigarettes as less harmful than conventional cigarettes,7 and e-
cigarette use among high school students (11.3%) now is more prevalent than combustible cigarette 
smoking (8.0%).8 In conjunction with recent aggressive advertising and promotion of new tobacco 
products,9 adolescents may be particularly susceptible to such products in future experimentation and 
use. 
Recently, adolescents exposed to e-cigarette advertising reported a significantly greater likelihood of e-
cigarette use compared to control groups.10 Other research shows an association of e-cigarette use by 
adolescents with subsequent initiation of traditional cigarette use.11 In a sample of 12 e-cigarette 
brands, levels of toxicants in e-cigarettes are found to be 9–450 times lower than cigarette smoke. Yet, 
they still contain significantly higher levels of six carcinogenic and toxic compounds (eg, formaldehyde, 
acetaldehyde, nitrosamines, cadmium, nickel, and lead) in comparison with the Nicorette inhaler.12 As 
e-cigarettes vaporize a propylene glycerol solution containing nicotine, a text addiction warning will be 
required for advertising and packaging.13 Users of e-cigarettes also risk respiratory exposure and 
potential lung disease due to aerosolized chemicals, including solvents, flavorants, adulterants, and 
other toxicants in the heating/aerosolization process.14 
The Family Smoking Prevention and Tobacco Control Act (FSPTCA)3 was signed in law on June 22, 2009 
giving the FDA authority to regulate the manufacture, marketing, and distribution of tobacco products 
in the United States (Sec. 901). Several interesting provisions of the Family Smoking Prevention and 
Tobacco Control Act include the use of modified risk tobacco products (MRTPs) and claims (Sec. 911 for 
e-cigarettes), proposed graphic health warnings (GHWs) (Sec. 201), disclosure of harmful constituents 
(Sec. 206), and the role of tobacco education to aid prevention and cessation.15,16 In its “deeming rule” 
extending its authority over all tobacco products, the FDA included a requirement for a nicotine 
warning regarding addiction.13,14 Also, there are two types of modified risk orders granted from the 
FDA for MRTPs: (1) a risk modification order (for products showing a significant reduction of harm and 
risk of tobacco-related disease) or (2) an exposure modification order (for products not shown to 
reduce risk/disease, yet are likely to do so because of a substantial reduction in exposure to harmful 
substances). For exposure modification products, consumers are not to be misled by the products’ 
labeling/marketing into believing that the product is less harmful than commercially marketed tobacco 
products. For example, an exposure claim of “fewer chemicals” may not be interpreted by consumers 
as meaning low (carcinogenic) risk or lower risk versus other cessation products. For risk modification 
claims (“fewer cancer-causing chemicals”), the applicant must demonstrate that the product will 
significantly reduce harm and risk of tobacco-related disease and benefit population health. Yet, the 
Institute of Medicine Report on MRTPs17 laments that “there is a dearth of credible and reliable 
evidence about MRTP safety, consumer perceptions, and individual and public health effects to guide 
federal regulatory decision.” The FDA’s MRTP Draft Guidance18 recommends that scientific studies as 
part of FDA MRTP applications include the ability of consumers to understand the modified risk claims 
and the health significance of the information. As e-cigarette ads have been making implicit and 
explicit risk claims,9 it is important to test warning information with such claims. 
To date, there have been no studies of different warning types and MRTP claims for adolescent 
experimenters exposed to e-cigarette ads. Therefore, our primary research objective is to conduct an 
experimental test of warning types (control, text-only, GHW and text) and modified risk ad claims 
(control, exposure reduction, risk reduction) for their impact on adolescent e-cigarette craving, evoked 
fear, risk beliefs, and future e-cigarette susceptibility. In a randomized experiment, one theme focuses 
on nicotine and addiction, and the other theme examines effects of potentially-harmful constituents 
(eg, flavored chemicals and lung cancer). 
In addition to testing modified risk claims, an important contribution of our study is the examination 
of different warning types, including text and GHWs. So far, the impact of GHWs have yet to be studied 
with e-cigarettes (see suggestions in Berry et al.19 and Wackowski et al.20). Although their use in the 
United States is currently blocked by a court ruling (unlike 109 other countries), considerable research 
on GHWs points to their effectiveness,21,22 for both adult23 and younger cigarette smokers.24–28 For 
example, in a study of dual pathways to persuasion from the GHWs, Andrews et al.24 found that both 
emotional responses (via evoked fear) and cognitive responses (via beliefs) affected quit thoughts. 
However, evoked fear was found to have a stronger effect than beliefs in mediating the effects of 
GHWs on quit thoughts for adolescent smokers, while this effect was reversed for young adult 
smokers. Moreover, research has shown that smoker attention and recall of health risk information is 
significantly improved with GHWs beyond that of text-only warnings.29 
Still, one’s prior knowledge and initial opinions can bias the scrutiny of externally-provided 
communications,30 such as with different harmful consequences and types of e-cigarette warnings. In 
the case of better known and more direct connections, such as the nicotine-addiction linkage,20 simple 
text warnings may be sufficient. However, in the case of emerging, yet potentially-harmful 
consequences of e-cigarette use, such as respiratory and lung disease problems, GHWs may be more 
effective, as shown in prior GHW research for combustible cigarettes. As one direct and widely-
conveyed purpose of e-cigarettes is to reduce dependence on traditional cigarettes, exposure and risk 
modification claims regarding less nicotine and addiction are likely to undercut and counter the 
addiction warning.19,31 Yet, this is likely not the case for exposure and risk modification claims about 
fewer (cancer-causing) chemicals with longer-term lung disease consequences. Based on prior warning 
and claim research, and the different consequence themes, it is predicted that: 
H1: For addiction: (a) Text-only warnings will lead to fewer e-cigarette cravings and less e-
cigarette susceptibility than for those exposed to a no warning (control) condition in e-cigarette 
ads. (b) No differences in e-cigarette craving and e-cigarette susceptibility are expected 
between the GHW + text condition versus the text-only condition. 
H2: For addiction: (a) An interaction between modified risk claim type and warning type is 
expected such that fewer e-cigarette cravings and less e-cigarette susceptibility are expected 
for the text-only warning and no claim (control) condition than for any other treatment 
conditions in e-cigarette ads. 
H3: For fatal lung disease: (a) The GHW + text condition will lead to fewer e-cigarette cravings 
and less e-cigarette susceptibility than for those exposed to either the text-only warning 
condition or no warning (control) condition in e-cigarette ads. (b) No differences in e-cigarette 
craving and e-cigarette susceptibility are expected between the text-only warning and no 
warning (control) conditions. (c) An interaction between modified risk claim type and warning 
type is not expected for e-cigarette cravings and e-cigarette susceptibility. 
Methods 
Sample and General Procedure 
Data Collection 
A professional marketing research firm with expertise in adolescent smoking research was used to 
collect the data. A double consent procedure was employed, that is, parents were first contacted to 
obtain permission and then the adolescent participants were asked for permission. Participants in the 
pretest and main experiment were adolescents aged 13–18, who indicated that they had tried or 
experimented with either cigarettes or e-cigarettes or both in their lifetime (80% were e-cigarette 
experimenters).32 
Pretest 
A pretest of 126 adolescents that had experimented with either cigarettes or e-cigarettes in their 
lifetime was used to help select the graphic visual warning from five pictures depicting addiction and 
then from five pictures depicting fatal lung disease (FLD) from around the world. Three age quotas (ie, 
13–14, 15–16, and 17–18), based on the University of Michigan Monitoring the Future data on 
adolescent smokers, were used to help ensure representative samples in all adolescent age groups. A 
50/50 split was made on gender to ensure equal representation in the samples, and experimentation 
with cigarettes or e-cigarettes32 was screened as well. Each adolescent was exposed to a randomly-
ordered set of five pictures depicting an addiction theme and then a randomly-ordered set of five 
pictures showing a FLD theme. They then were asked a set of questions regarding perceived 
graphicness, evoked fear, fit with a text warning on addiction (or fatal lung disease) under each picture, 
and picture believability. For the key measure of graphicness, each respondent evaluated the given 
picture on four, 7-point scales: graphic–not graphic; vivid–not vivid; powerful–weak; and intense–not 
intense; average 𝛼𝛼 =  .91).23,24 A single item, 7-point measure assessed the picture fit with a text 
warning of “addiction” (or “fatal lung disease”), and a second, 7-point measure assessed the perceived 
believability of the picture. The text warnings stated either: “WARNING: E-cigarettes are addictive” or 
“WARNING: E-cigarettes may case fatal lung disease.” The level of evoked fear from each picture was 
measured with four, 7-point scales: fearful–not fearful; afraid–not afraid; anxious–not anxious; and 
nervous–not nervous; average 𝛼𝛼 =  .92).23,24 Standardized mean scores were calculated and 
confidence intervals within each theme showed pictures that were significantly different from one 
another (𝑝𝑝 ≤  .05). The graphicness and evoked fear results for addiction indicated that the picture 
showing smoking through a stoma hole was significantly more graphic and evoked more fear than the 
other four pictures tested. This picture also produced text warning fit (𝑀𝑀 =  5.98) and perceived 
believability (𝑀𝑀 =  6.12) scores greater than the respective scale mid-points. For fatal lung disease, 
the graphicness and evoked fear measures indicated that the picture depicting before-after FLD on a 
white background was significantly more graphic and evoked greater fear than the other four pictures 
tested. This picture also resulted in text warning fit (𝑀𝑀 =  6.03) and perceived believability (𝑀𝑀 =
 6.03) scores greater than the respective scale mid-points. 
The two claims in the addiction ads (ie, for exposure modification: “Less Nicotine, More Freedom”; for 
risk modification: “Less Nicotine, Less Addicting, More Freedom”) and two claims in the FLD ads (ie, for 
exposure modification: “Fewer Chemicals, More Freedom”; for risk modification: “Fewer Cancer-
Causing Chemicals, More Freedom”) were tested for claim strength (A control claim just mentioned 
“More Freedom” in the ad). Claim strength was measured on 7-point scales with the following five 
items: weak-strong, unpersuasive-persuasive, not convincing-convincing, a bad claim-a good claim, not 
believable-believable33; all 𝛼𝛼 >  .94). Mean values for claim strength for all four ad claims were above 
5 on the 7-point scale. 
Main Study Procedure, Sample and Design 
The main experiment again used a double consent procedure (ie, parents gave their permission, then 
adolescent participants) before being screened on age, gender, and use of either cigarettes or e-
cigarettes in their lifetime (80% had used e-cigarettes). The total study sample consisted of 1011 
adolescents experimenting with smoking32 with quotas producing a 50/50 split on gender and age 
categories of 15% (13–14 years), 33% (15–16 years), and 52% (17–18 years) based on the University of 
Michigan Monitoring the Future data. Following screening questions, respondents were told they first 
would be answering some questions about cigarettes and electronic cigarettes, “…also known as e-
cigarettes, e-cigs, cig-alikes, personal vaporizers, or vapor cigs….”. They also were told they would be 
viewing an e-cigarette ad. After successful screening for consent and quotas, respondents were 
randomly assigned to one of nine experimental versions of an e-cigarette ad for either addiction 
(Theme 1) or FLD (Theme 2). Based on the FDA e-cigarette deeming rules13 and the Family Smoking 
Prevention and Tobacco Control Act,3 the top center of the ad displayed the health warning (if 
included) and covered 20% of the ad space. The bottom portion displayed the ad claim (if made). The 
same warnings and ad claims discussed in the pretest were used in the main study experiments. Thus, 
each main study experiment used a 3 (warning type: absent/control, text-only, text + GHW) × 3 (claim 
type: absent/control, exposure modification, risk modification) between-subjects design. The most 
widely-advertised electronic cigarette brand (blu) was used as a basis for ad stimuli. This brand 
recorded a 256% increase in youth TV ad target rating points over a recent 2-year period.9 
Main Study Measures 
Key dependent variables of interest included e-cigarette craving (single-item, 7-point scale) and future 
e-cigarette susceptibility (four-item, 7-point scale, 𝛼𝛼 =  .97). Evoked fear (four-item, 7-point scale, 
𝛼𝛼 =  .96) and risk beliefs (single-item, 7-point scale) also were assessed. E-cigarette craving was 
measured by asking respondents, “After having viewed the e-cigarette ad, how much do you want to 
smoke an e-cigarette right now?” with endpoints of “not at all”–“very much.”25,34 The evoked fear 
measure asked respondents how the e-cigarette ad made them feel with endpoints of “not fearful”–
“very fearful”; “not afraid”–“very afraid”; “not nervous”–“very nervous”; and “not anxious”–“very 
anxious.”23,24 For e-cigarette risk beliefs, respondents were asked whether “Using e-cigarettes can be 
additive” (“strongly disagree–strongly agree”) and whether “Using e-cigarettes may increase the risk of 
fatal lung disease” (“strongly disagree–strongly agree”). Future e-cigarette susceptibility was measured 
on 7-point scales by the following: (1) “Do you think you will try an e-cigarette soon?” (“definitely not–
definitely yes”), (2) “If you had the opportunity to try an e-cigarette today, how likely would you do it?” 
(“not at all likely–very likely”), (3) “If one of your best friends offered you an e-cigarette, would you try 
it?” (“definitely not–definitely yes”), and (4) “Do you think you will try an e-cigarette in the next year?” 
(“definitely not–definitely yes”).24,32,35 
Results 
A manipulation check assessed the graphic level of the ads. Those exposed to the GHW condition 
(𝑀𝑀 =  5.05) felt the warning was significantly more graphic (on the four, 7-point scales used in the 
pretest) than those exposed to either the text-only warning (𝑀𝑀 =  4.50) or control conditions (𝑀𝑀 =
 3.55;  𝐹𝐹 =  65.01;  𝑝𝑝 ≤  .01). The means (and lower bound of 95% confidence intervals) for the 
believability and credibility of the text box information, as well as for the ad claim information, were all 
above 4.7 and the mid-point (4) of the scales. 
For both the addiction and lung disease themes, a multivariate analysis of covariance (MANCOVA) was 
conducted to examine main effects for warning type, ad claim type, and interaction effects between 
the warning and claim types. Age and gender served as covariates. All adolescents had indicated that 
they had either smoked a cigarette or tried/experimented with smoking a cigarette in their 
lifetime,32 and 80% had experimented with e-cigarettes. Table 1 shows the overall multivariate and 
univariate findings for the addiction theme, as well as the marginal means and standard deviations for 
each independent variable for this theme. Table 2 displays the same analysis, but for the FLD theme. 
  
Table 1. Multivariate and Univariate Results: Adolescent Experimenters: Addiction  
MANCOVA 
results 
 Univariate 
results 
   
Independent variables Wilks’ λ F-value E-cigarette 
craving 
Evoked fear Addiction 
belief 
E-cigarette 
susceptibility 
Main effects              
 Warning type (W)  0.92  4.95***  2.09  11.86***  7.94***  3.20**  
 Claim type (C)  0.99  0.69  1.64  0.45  0.71  0.70  
Interaction effects              
 W × C  0.94  2.02***  3.36***  1.61  1.57  3.43***  
Means (and Standard Deviations) for 
the Effects of Warning Type (W) and 
Claim Type (C) Conditions on 
Adolescent Experimenters: Addiction  
      
    E-cigarette 
craving  
Evoked fear  Addiction 
belief  
E-cigarette 
susceptibility  
Warning type            
 Control (a)    4.11 (2.02)  2.67 (1.58)b,c  4.93 (1.69)b,c  4.19 (1.98)b  
 Text only (b)    3.72 (2.02)  3.39 (1.78)a  5.52 (1.41)a  3.66 (2.04)a  
 Text + graphic (c)    3.68 (1.91)  3.38 (1.81)a  5.53 (1.51)a  3.97 (2.08)  
Claim type            
 Control (a)    3.70 (2.05)  3.18 (1.79)  5.37 (1.56)  3.86 (2.07)  
 Exposure mod (b)    3.76 (1.90)  3.06 (1.76)  5.41 (1.51)  3.86 (2.04)  
 Risk mod (c)    4.06 (2.03)  3.18 (1.72)  5.17 (1.63)  4.10 (2.02)  
MANCOVA = multivariate analysis of covariance; SNK = Student-Newman-Keuls. In the lower panel, comparisons are made going down a column. 
Superscripts adjacent to the means for a given column in the table indicate significant differences (p ≤ .05 or better) according to SNK contrasts based on 
predictions. For example, for the evoked fear column and comparing warning types, the superscript for the “c” cell (Text + graphic) indicates that the 
evoked fear mean is significantly greater than the mean for the control cell labeled “a”. 
*p < .10; **p < .05; ***p < .01, N = 491. Other interactions are nonsignificant for all dependent measures. Covariates = age, gender. 
 
  
Table 2. Multivariate and Univariate Results: Adolescent Experimenters: Fatal Lung Disease (FLD)  
MANCOVA 
results 
 Univariate 
results 
   
Independent variables Wilks’ λ F-value E-cigarette 
craving 
Evoked fear FLD belief E-cigarette susceptibility 
Main effects              
 Warning type (W)  0.84  10.73***  6.53***  29.37***  23.25***  6.53***  
 Claim type (C)  0.99  0.93  0.80  1.28  0.38  1.77  
Interaction effects              
 W × C  0.98  1.53  0.55  0.57  0.21  1.36  
Means (and Standard Deviations) 
for the Effects of Warning Type (W) 
and Claim Type (C) Conditions on 
Adolescent Experimenters: Fatal 
Lung Disease (FLD)  
      
    E-cigarette 
craving  
Evoked fear  FLD belief  E-cigarette susceptibility  
Warning type      
  
     
 Control (a)    4.05 (2.08)c  2.99 (1.88)b,c  4.40 (1.82)b,c  4.15 (2.10)c  
 Text only (b)    3.98 (2.12)c  3.89 (1.91)a,c  5.22 (1.68)a  4.00 (2.14)c  
 Text + graphic (c)    3.33 (2.22)a,b  4.61 (1.80)a,b  5.58 (1.60)a  3.40 (2.19)a,b  
Claim type            
 Control (a)    3.92 (2.21)  3.63 (2.02)  5.01 (1.90)  4.07 (2.20)  
 Exposure mod (b)    3.66 (2.07)  3.99 (1.92)  5.02 (1.75)  3.64 (2.08)  
 Risk mod (c)    3.82 (2.13)  3.79 (1.97)  5.10 (1.68)  3.89 (2.19)  
MANCOVA = multivariate analysis of covariance; SNK = Student-Newman-Keuls. In the lower panel, comparisons are made going down a column. 
Superscripts adjacent to the means for a given column in the table indicate significant differences (p ≤ .05 or better) according to SNK contrasts based on 
predictions. For example, for the e-cigarette craving column and comparing warning types, the superscripts for the “c” cell (Text + graphic) indicate that 
the e-cigarette craving mean is significantly less than the mean for the cells labeled “a” and “b.” 
*p < .10; **p < .05; ***p < .01, N = 486. Other interactions are nonsignificant for all dependent measures. Covariates = age, gender. 
 
  
Theme 1: Addiction Effects for Warning Type 
Hypothesis 1a predicted that text-only warnings should result in fewer e-cigarette cravings and less e-
cigarette susceptibility than will a no warning (control) condition. Partially supporting H1a, our findings 
in Table 1 indicate that although warning type did not reach significance on e-cigarette craving (𝐹𝐹 =
 2.09,  𝑝𝑝 =  .13), it had a significant effect on e-cigarette susceptibility (𝐹𝐹 =  3.20,  𝑝𝑝 ≤  .05). As 
shown in Table 1, Student-Newman-Keuls (SNK) contrasts indicate that the text-only warning (𝑀𝑀 =
 3.66) significantly reduced e-cigarette susceptibility for adolescent experimenters compared to no 
warning control (𝑀𝑀 =  4.11) condition (𝑝𝑝 ≤  .05). All null hypothesis significance tests were 
conducted with 95% inferential confidence intervals using procedures outlined in Muthusamy et 
al.36 In Table 1, as predicted, there were no significant differences for e-cigarette craving between the 
GHW + text (𝑀𝑀 =  3.68) and text-only conditions (𝑀𝑀 =  3.72,  𝑝𝑝 ≥  .20) offering partial support for 
H1b. However, GHW + text condition (𝑀𝑀 =  3.97) produced greater e-cigarette susceptibility than the 
text-only condition (𝑀𝑀 =  3.66). 
Addiction Theme Interaction Effects for Warning and Claim Types 
Hypothesis 2 predicted an interaction between warning type and modified risk ad claim type. It was 
expected that a greater reduction in e-cigarette craving and in e-cigarette susceptibility would occur 
for the text-only warning for no claim (control) condition, but this warning would be less effective 
when modified risk ad claims were made. The results in Table 1 and Figure 1 show a significant warning 
type x ad claim type effect for both e-cigarette craving (𝐹𝐹 =  3.36,  𝑝𝑝 ≤  .01) and e-cigarette 
susceptibility (𝐹𝐹 =  3.43,  𝑝𝑝 ≤  .01) (As noted in Table 1, this interaction was not significant for evoked 
fear and the addiction belief.). In support of H2, when the text-only warning was displayed, the no 
claim control (𝑀𝑀 =  2.95) led to significantly fewer e-cigarette cravings than found with the exposure 
modification claim (𝑀𝑀 =  3.92,  𝑝𝑝 ≤  .05) and risk modification claim conditions (𝑀𝑀 =  4.26,  𝑝𝑝 ≤
 .05). Also, in support of H2, when the text-only warning was shown, the no claim control (𝑀𝑀 =  3.06) 
led to significantly less e-cigarette susceptibility than found with the risk modification claim conditions 
(𝑀𝑀 =  4.11,  𝑝𝑝 ≤  .05). The no claim control led to marginally significant and less e-cigarette 
susceptibility than the exposure modification claim condition (𝑀𝑀 =  3.78,  𝑝𝑝 ≤  .10). 
  
Figure 1. Effects of warning type and claim type on e-cigarette craving and susceptibility (addiction 
theme). 
 
 
Theme 2: FLD Effects for Warning Type 
For the FLD theme, there were main effects for warning type for both e-cigarette craving (𝐹𝐹 =
 6.53,  𝑝𝑝 ≤  .01) and e-cigarette susceptibility (𝐹𝐹 =  6.53,  𝑝𝑝 < .01). In support of H3a, and found 
in Table 2, the GHW + text condition (𝑀𝑀 =  3.33) led to significantly fewer e-cigarette cravings than 
found with the text-only warning (𝑀𝑀 =  3.98,  𝑝𝑝 ≤  .05) and no control warning conditions (𝑀𝑀 =
 4.05,  𝑝𝑝 ≤  .05). Also, in support of H3a, the GHW + text condition (𝑀𝑀 =  3.40) led to significantly less 
e-cigarette susceptibility than found with the text-only warning (𝑀𝑀 =  4.00,  𝑝𝑝 <  .05) and no control 
warning conditions (𝑀𝑀 =  4.15,  𝑝𝑝 <  .05). In support of H3b, and as noted in Table 2, there were no 
differences between the text-only warning and no warning control conditions for both e-cigarette 
craving and susceptibility (Yet, as Table 2 reveals, both the GHW + text and text-only conditions 
significantly increased evoked fear and the FLD belief compared to the control condition.). In support 
of H3c, there was not an interaction between warning type and the modified risk claim type, as the 
relatively strong effects of the GHW + text condition occurred across all claim types. Finally, a 
comparison of e-cigarette beliefs asked of all respondents in the no warning control condition revealed 
that their prior knowledge (ie, belief) regarding addiction and e-cigarette use (𝑀𝑀 =  4.93) was 
significantly greater than that for that of FLD and e-cigarette use (𝑀𝑀 =  4.38; paired 𝑡𝑡 =  6.85,  𝑝𝑝 ≤
 .01). 
Discussion 
Most experimental research on e-cigarette warnings has involved text-only conditions and not the 
GHWs, nor warnings in the presence of modified risk ad claims. Evidence exists that general health 
claims can undercut text-only warnings for adult smokers37 and nonsmokers.31 Yet, as noted in 
Wackowski et al.,20 recent interviews with e-cigarette research experts reveal that “…more than one 
warning would be important as e-cigarette science evolves and that research on additional warning 
themes (eg, nicotine exposure, harmful constituents) and execution styles (including the use of 
pictorials)” is needed. Our research sought to address these shortcomings for an at-risk sample of over 
1000 adolescent experimenters exposed to different warning types (eg, text-only, text + GHW, no 
warning control), different modified risk ad claims (eg, exposure reduction, risk reduction, no claim 
control), and for two separate e-cigarette themes (addiction, FLD). 
Our results indicate that, for the addiction theme, the text-only warning led to significantly less e-
cigarette susceptibility than the no warning control condition. As predicted, there were no differences 
between the GHW + text condition and text-only condition for e-cigarette craving. However, the GHW 
+ text warning led to greater e-cigarette susceptibility than the text-only condition. An interaction 
between warning type and modified risk claims revealed significantly fewer e-cigarette cravings and 
less susceptibility for the text-only warning and no claim (control) condition than for any other 
condition. In the case of the FLD theme, the GHW + text condition led to fewer e-cigarette cravings and 
less susceptibility than the text-only warning and no warning (control) conditions. For both the 
addiction and lung disease themes, the inclusion of the text and GHW + text warnings also increased 
risk beliefs and evoked fear, relative to the no warning control condition. These results support the 
inclusion of warning messages in e-cigarette ads and across different ad claim conditions. 
Limitations and Future Research Issues 
Our randomized experimental study manipulated e-cigarette warnings and modified risk ad claims 
shown to adolescent experimenters for two separate themes (addiction, lung disease); offering 
support for the study’s internal validity. Yet, although the online exposure context, sample focus, 
stimuli tested, measures used, and parental and adolescent consents (to meet IRB requirements) are 
consistent with prior tobacco warning research,23,24 they could serve to limit the generalizability of 
findings. For example, further validation work with e-cigarette craving and susceptibility measures may 
be warranted. No doubt, there can be other e-cigarette warning themes to consider, other country 
samples, smoking frequencies/situations32 (eg, progression from experimenters to any 30-day use to 
daily smokers), different modified risk ad claims, and other e-cigarette brands and tobacco products to 
examine (eg, hookah, cigars, cigarillos, smokeless tobacco).38 Also, mediation analysis may reveal 
interesting pathways to e-cigarette susceptibility from the warning and ad claim types. Future research 
might consider using longitudinal data to examine any possible wear-out patterns. Efforts in this regard 
will help contribute to a better understanding of how at-risk adolescents will react to the provision of 
important e-cigarette information, like different warning types in the presence of modified risk 
claims—all with the ultimate objective of reducing youth dependence on tobacco. 
Conclusions and Policy Implications 
In previous GHW research,23,24 the level of graphicness proved to be important in affecting intentions 
to quit for adolescent smokers. Yet, considering emerging scientific evidence for e-cigarettes, we find 
that warning type effects, including that for GHWs, can be quite different under different focal themes 
(eg, addiction, FLD). One possible explanation for our results is that greater prior knowledge on 
addiction and e-cigarettes may have lessened GHW effects, indicating the sufficiency of text-only 
warnings, whereas less prior knowledge of FLD and e-cigarettes may have strengthened GHW effects 
relative to other warning types. An alternative explanation is that certain smoking diseases (eg, lung 
cancer, mouth cancer) may be easier to depict visually, evoke greater fear (as Table 2 indicates for lung 
disease), and are more congruent with text warning information than for other health risks, such as 
addiction.39 Also, we find that relative exposure and risk modification claims (eg, less nicotine; less 
addicting) tend to undercut addiction warnings. Due to the emerging research on e-cigarettes, it is 
important to first know exactly what at-risk populations believe about different harmful consequences 
of use, and perceptions of GHW visuals, to better understand what type of warning might be most 
effective, especially in the presence of ad claims. This is likely to be helpful in research by federal 
agencies (eg, FDA) and for those in public health in best conveying the most appropriate e-cigarette 
warnings to at-risk populations, such as susceptible youth. 
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